Company B.R.A.I.N. Biotechnology Research and Information Network AG OTC Markets
Stocks
BRNB.F
DE0005203947
Environmental Services & Equipment
Business description: B.R.A.I.N. Biotechnology Research and Information Network AG
Number of employees: 280
Sales by Activity: B.R.A.I.N. Biotechnology Research and Information Network AG
| Fiscal Period: September | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Brainbiocatalysts | - | - | - | - | 45.8M |
BRAINBioincubator | - | - | 944K | 2.05M | 4.41M |
Bioproducts | 28.3M | 37.7M | 42.64M | 42.64M | - |
Reconciliation | -159K | -118K | -39K | -286K | - |
Bioscience (excl. Bioincubator) | - | - | 12.68M | 11.1M | - |
Bio Science | 11.08M | 12.71M | - | - | - |
Geographical breakdown of sales: B.R.A.I.N. Biotechnology Research and Information Network AG
| Fiscal Period: September | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Other Abroad | 10.7M | 13.58M | 16.47M | 16.58M | 16.48M |
USA | 8.86M | 14.02M | 15.31M | 13.51M | 12.3M |
Netherlands | 4.98M | 6.54M | 10.38M | 11.28M | 8.85M |
Germany | 7.07M | 7.93M | 5.66M | 6.65M | 5.52M |
United Kingdom | 3.7M | 3.64M | 4.77M | 3.68M | 4.3M |
France | 3.08M | 3.8M | 2.74M | 2.92M | 2.18M |
Executive Committee: B.R.A.I.N. Biotechnology Research and Information Network AG
| Manager | Title | Age | Since |
|---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 62 | 2020-01-31 |
| Director of Finance/CFO | 56 | 2022-09-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 40 | 2022-12-31 |
Martina Schuster
IRC | Investor Relations Contact | - | - |
Robert Hoekstra
PRN | Corporate Officer/Principal | - | 2022-03-31 |
Composition of the Board of Directors: B.R.A.I.N. Biotechnology Research and Information Network AG
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 2017-03-08 | |
Michael Majerus
CHM | Chairman | 65 | 2023-03-07 |
Stephen Catling
BRD | Director/Board Member | 61 | 2020-10-13 |
Christine Uekert
BRD | Director/Board Member | 62 | 2023-03-07 |
Florian Schnabel
BRD | Director/Board Member | 56 | 2023-03-07 |
| Director/Board Member | 58 | 2025-07-10 |
Company details: B.R.A.I.N. Biotechnology Research and Information Network AG
BRAIN Biotech AG
Darmstädter Strasse 34-36
64673, Zwingenberg
+49 62 51 9331 0
http://www.brain-biotech.de
Environmental Biotechnology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.38% | +3.97% | -38.50% | -77.06% | 234M | |
| +1.11% | +12.35% | +361.93% | +536.36% | 157M | |
| +1.05% | +19.01% | +2.86% | -47.83% | 86.25M | |
| Average | +1.18% | +11.78% | +108.76% | +137.16% | 159.2M | |
| Weighted average by Cap. | +1.23% | +9.44% | +100.51% | +129.74% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
